In Thursday’s Wall Street session, Astera Labs Inc (NASDAQ:ALAB) shares traded at $97.02, down -2.84% from the previous session.
ALAB stock price is now 9.89% away from the 50-day moving average and 11.09% away from the 200-day moving average. The market capitalization of the company currently stands at $16.00B.
On May 16, 2025, Susquehanna recently initiated its ‘Neutral’ rating on the stock quoting a target price of $80, while ‘Morgan Stanley’ rates the stock as ‘Overweight’
In other news, Jitendra Mohan, CEO, Director bought 394,050 shares of the company’s stock on May 14 ’25. The stock was bought for $34,581,828 at an average price of $87.76. An SEC document containing details of the transaction can be found on the SEC’s website. On Jul 02 ’25, Director ALBA MANUEL sold 63,000 shares of the business’s stock. A total of $5,666,779 was realized by selling the stock at an average price of $89.95. This leaves the insider owning 420,854 shares of the company worth $40.83 million. A total of 23.71% of the company’s stock is owned by insiders.
During the past 12 months, Astera Labs Inc has had a low of $36.22 and a high of $147.39. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 13.92, and a quick ratio of 13.26. According to the stock market information, the enterprise value for the company is $13987052544, which is based on a 413.55 price-to-earnings ratio, a 9.92 price-to-earnings-growth ratio, and a beta of 1.19. The fifty day moving average price for ALAB is $88.29 and a two-hundred day moving average price translates $87.335526 for the stock.
The latest earnings results from Astera Labs Inc (NASDAQ: ALAB) was released for 2025-03-31. The net profit margin was 8.44% and return on equity was 4.47% for ALAB. The company reported revenue of $159.44 million for the quarter, compared to $65.26 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 144.33 percent.
